Enzo Biochem, Inc. (ENZ) Misses Q1 Views
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
CCEL, FEIM, PLG, More
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q1 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $25.75 million versus the consensus estimate of $27.04 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Delta Air Lines Q2 earnings preview: softer profit expected amid fuel price headwinds
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
